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Abstract
Prenatal exposure to maternal infection increases the risk of neurodevelopmental disorders, including schizophrenia and
autism. The molecular processes underlying this pathological association, however, are only partially understood. Here, we
combined unbiased genome-wide transcriptional proﬁling with follow-up epigenetic analyses and structural magnetic
resonance imaging to explore convergent molecular and neuromorphological alterations in corticostriatal areas of adult
offspring exposed to prenatal immune activation. Genome-wide transcriptional proﬁling revealed that prenatal immune
activation caused a differential expression of 116 and 251 genes in the medial prefrontal cortex and nucleus accumbens,
respectively. A large part of genes that were commonly affected in both brain areas were related to myelin functionality and
stability. Subsequent epigenetic analyses indicated that altered DNA methylation of promoter regions might contribute to the
differential expression of myelin-related genes. Quantitative relaxometry comparing T1, T2, and myelin water fraction revealed
sparse increases in T1 relaxation times and consistent reductions in T2 relaxation times. Together, our multi-system approach
demonstrates that prenatal viral-like immune activation causes myelin-related transcriptional and epigenetic changes in
corticostriatal areas. Even though these abnormalities do not seem to be associated with overt white matter reduction, they
may provide a molecular mechanism whereby prenatal infection can impair myelin functionality and stability.
Key words:Magnetic resonance imaging (MRI), maternal immune activation, myelin, poly(I:C), schizophrenia, transcriptome
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Introduction
The etiology of multifactorial and multi-symptomatic neuro-
psychiatric disorders likely includes exposures to adverse
events during prenatal and early postnatal life, which may dis-
rupt the development and maturation of neural systems and
brain functions (Brown 2011). Prenatal exposure to infectious or
inﬂammatory insults is increasingly recognized to play an
important role in this context. Indeed, immune-related pre-
natal adversities have been repeatedly linked with a higher risk
of neurodevelopmental psychiatric disorders, including schizo-
phrenia, autism, and bipolar disorder (Brown and Derkits 2010;
Patterson 2011; Marangoni et al. 2016). These epidemiological
associations are further supported by translational work in ani-
mal models demonstrating abnormal brain development and
behavioral dysfunctions following prenatal administration of
infectious pathogens or immune activating agents (Meyer and
Feldon 2010; Harvey and Boksa 2012; Meyer 2014).
The advances in modeling prenatal immune activation
effects in animals hold promise for the identiﬁcation of patho-
logical mechanisms that translate the prenatal insult into long-
term brain abnormalities. The majority of these experimental
attempts, however, were hypothesis-driven and focused on the
role of a speciﬁc cellular or molecular mechanism, pathway or
system (Eyles et al. 2012; Ibi and Yamada 2015). While this is a
laudable and possibly fruitful approach for the examination of a
presumed pathophysiological process, hypothesis-driven investi-
gations may mask the discovery of novel disease mechanisms.
The implementation of genome-wide transcriptional proﬁling
is one possible strategy to overcome these limitations. It allows
an unbiased screen of gene expression changes in response to
prenatal immune activation, which can form the basis for follow-
up investigations that take into account this transcriptomic infor-
mation (Fatemi et al. 2005, 2008, 2009a; Connor et al. 2012;
Tebbenkamp et al. 2014; Horvath and Mirnics 2015). The present
study followed such an approach, in which unbiased transcrip-
tomic proﬁling formed the basis for subsequent immunohisto-
chemical investigations and epigenetic analyses. Genome-wide
transcriptomic proﬁling was performed using unbiased micro-
array techniques in the medial prefrontal cortex (mPFC) and
nucleus accumbens (NAc), 2 brain regions implicated in neurode-
velopmental disorders such as schizophrenia and autism (Richey
et al. 2015; Schubert et al. 2015; Selemon and Zecevic 2015). The
inclusion of 2 brain regions allowed us to identify region-speciﬁc
and -overlapping transcriptomic effects of prenatal immune acti-
vation using a within-subjects comparison. These investigations
were performed in offspring that were ﬁrst subjected to behav-
ioral and cognitive testing.
We also explored whether microscale molecular alterations
reverberate to inﬂuence macroscale features that are detectable
using clinically comparable magnetic resonance imaging (MRI)
(Turkheimer et al. 2015). As an adjunct to cellular and molecular
methods, MRI provides a non-invasive global visualization of
brain maturation, through the evolution of gray and white mat-
ter contrast on T1 and T2 relaxation time-weighted images
(Ballesteros et al. 1993; Paus et al. 2001; Leppert et al. 2009). We
further implemented a novel multicomponent relaxation (MCR)
technique termed multicomponent-driven equilibrium single
pulse observation of T1 and T2 (mcDESPOT) (Deoni et al. 2008a) to
provide quantitative information about proton tissue water
relaxation times and myelin water fraction (MWF) signals. This
technique aims to divide the MR signal resulting from steady-
state sequences into 3 pools representing water trapped in the
myelin sheath, intra-extracellular water, and free water in cere-
brospinal ﬂuid (Deoni et al. 2008b, 2013). Whilst applied in
human imaging before (Deoni et al. 2011, 2012), we have recently
validated the mcDESPOT methodology in rodents using a model
of cuprizone-induced demyelination (Wood et al. 2016a, 2016b).
All investigations were performed using a well-established
mouse model of prenatal viral-like immune activation. The
model is based on maternal administration of the viral mimetic
poly(I:C) (=polyriboinosinic-polyribocytidilic acid), which induces a
cytokine-associated viral-like acute phase response in maternal
and fetal compartments, including the fetal brain (Meyer et al.
2009). Prenatal poly(I:C) treatment in rodents has repeatedly
been shown to cause multiple behavioral and cognitive distur-
bances in the offspring, many of which are implicated in devel-
opmental psychiatric disorders such as schizophrenia and
autism (Meyer et al. 2009; Meyer and Feldon 2010; Harvey and
Boksa 2012; Meyer 2014). The poly(I:C) administration model
thus offers a unique opportunity to explore genome-wide tran-
scriptomic changes following prenatal exposure to an etiologic-
ally relevant risk factor, and to further link such changes with
neurobehavioral and MRI-detectable abnormalities.
Materials and Methods
Animals
C57Bl6/N mice were used throughout the study. Female and
male mice were originally obtained from Charles River Labora-
tories (Germany) and kept in our in-house speciﬁc-pathogen-
free (SPF) facility until breeding began to generate poly(I:C)-
exposed and control offspring (see below). All animal breeding
and holding rooms were temperature- and humidity-controlled
(21 ± 1°C, 55 ± 5%) and kept under a reversed light–dark cycle
(lights off: 7:00 A.M. to 7:00 P.M.). All animals had ad libitum
access to food (Kliba 3430, Kaiseraugst, Switzerland) and water
throughout the entire study. All procedures described in the
present study had been previously approved by the Cantonal
Veterinarian’s Ofﬁce of Zurich, and all efforts were made to
minimize the number of animals used and their suffering.
Maternal Immune Activation during Pregnancy
Female C57Bl6/N mice were subjected to a timed mating proced-
ure as described previously (Meyer et al. 2005). Pregnant dams on
gestation day (GD) 17 were randomly assigned to receiving either
a single injection of poly(I:C) (potassium salt; Sigma-Aldrich,
Buchs, St Gallen, Switzerland) or vehicle. Poly(I:C) (5mg/kg; calcu-
lated based on the pure form of poly(I:C)) was dissolved in sterile
pyrogen-free 0.9% NaCl (vehicle) solution to yield a ﬁnal concen-
tration of 1mg/mL and was administered intravenously (i.v.) into
the tail vein under mild physical constraint. The dose of poly(I:C)
was selected based on previous dose–response studies (Meyer
et al. 2005). 10 pregnant dams were injected with poly(I:C), and
another 10 with vehicle solution.
GD 17 in the mouse roughly corresponds to human gesta-
tional weeks 28 to 29 in terms of cortical neurogenesis (http://
translatingtime.net/translate). It was selected based on previ-
ous studies showing that prenatal poly(I:C) exposure during
this gestational period causes adult behavioral, cognitive, and
neuroanatomical abnormalities relevant to neurodevelopmen-
tal brain disorders, including schizophrenia and autism
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(Meyer et al. 2006, 2008; Bitanihirwe et al. 2010a, 2010b;
Richetto et al. 2013, 2014, 2015). We previously veriﬁed that
poly(I:C) administration on GD 17 is effective in terms of eli-
citing cytokine-associated inﬂammatory response in maternal
and fetal tissues (Meyer et al. 2006).
Allocation of Offspring and Group Sizes
Offspring of poly(I:C)-treated dams (POL) and vehicle-exposed
control offspring (CON) were weaned and sexed on postnatal
day (PND) 21. Littermates of the same sex were caged separ-
ately and maintained in groups of 3 to 4 animals per cage. Only
male animals were included in all experiments because our
previous research using the mouse prenatal poly(I:C) adminis-
tration model did not reveal sex-dependent effects on the
behavioral and cognitive functions of primary interest, includ-
ing social interaction and working memory (Meyer et al. 2008;
Bitanihirwe et al. 2010a; Richetto et al. 2013). A ﬁrst cohort of
CON and POL offspring was used for the assessment of behav-
ioral and cognitive functions, which was followed by post-
mortem microarray analyses, validation of gene expression, and
DNA methylation analyses (see below). A second cohort of off-
spring was used for ex vivo MRI imaging and subsequent post-
mortem immunohistochemical analyses (see below). In both
cohorts, 1 male offspring per litter was randomly selected for
the investigations of interest in order to avoid litter effects
(Zorrilla 1997). This led to a group size of N = 10 offspring per
prenatal treatment condition in each cohort. The DNA methy-
lation analyses were performed using a subset of offspring,
with N = 5 offspring per prenatal treatment condition. A graph-
ical representation of the experimental design is provided in
Supplementary Figure 1.
Behavioral Testing
CON and POL offspring of cohort 1 were subjected to cognitive
and behavioral testing when they reached early adulthood (12
weeks of age). The tests included paradigms assessing social
approach behavior, and social recognition, and short-term spa-
tial recognition memory working. These tests were selected
based on their relevance to neurodevelopmental disorders with
infectious and inﬂammatory components, including schizo-
phrenia and autism (Meyer et al. 2009; Peleg-Raibstein et al.
2012). A detailed description of the test apparatuses and proce-
dures is provided in the Supplementary Information. Each ani-
mal underwent all behavioral tests in the following order: (1)
spatial recognition memory test and (2) social approach and
recognition test. A test-free resting period of 2 days was
imposed between the 2 tests.
Collection of Brain Samples for Molecular Analyses
CON and POL offspring of cohort 1 were killed by decapitation
10 days after completion of behavioral testing for the subsequent
molecular analyses. The brains were rapidly extracted from the
skull (within < 20 s) and placed on an ice-chilled plate. This
was followed by preparing 1-mm coronal brain sections using
razorblade cuts and subsequent micro-dissection of the brain
areas of interest. We dissected the medial prefrontal cortex
(mPFC, including anterior cingulate, prelimbic and dorsal parts
of the infralimbic cortices; bregma: +2.3 to +1.3mm) and the
nucleus accumbens (NAc, including core and shell subregions;
bregma +1.5 to +0.5mm) as previously described (Bitanihirwe
et al. 2010a). Brain specimens were collected in 96-well
microtiter plates kept on dry ice and allowed to freeze before
storage at −80°C until further use.
DNA and RNA Isolation
Total DNA and RNA were isolated using the Qiagen AllPrep
DNA and RNA Mini kit (Qiagen, Italy) as described in the
Supplementary Information.
Microarray Analyses
Genome-wide gene expression analyses were performed using
Affymetrix microarray assays (Mouse Gene 1.1 ST Array Strips
on GeneAtlas platform), following the 3’IVT one cycle labeling
as fully described in the Supplementary Information. All the
raw data are accessible at the NCBI GEO depository (GEO acces-
sion number GSE77973). The data analysis was performed with
Partek Genomics Suite (Partek, USA), version 6.6 (for details, see
Supplementary information). Differentially expressed genes
(DEGs) in POL offspring relative to CON offspring were identiﬁed
by performing a linear contrast (POL versus CON). In this com-
parison, a maximum ﬁlter of P < 0.05 and a minimum absolute
fold change cut-off of 1.2 were applied. The DEGs were loaded
into Partek Genomics Suite and were clustered according to the
Hierarchical Clustering function of Partek Genomics Suite. For
this purpose, the data was normalized with standardization
(each column mean is 0, and the standard deviation is scaled to
1), and then multidimensional scaling with a Euclidian distance
metric was performed on the normalized samples to allow
visualization of the distance between them. To conﬁrm that
the overlapping changes were not due to random distribution,
we performed the hyper-geometric test in R (P = 5.765284e14).
Gene Ontology enrichment analyses were performed using
Partek Genomics Suite (Partek, USA). Subsequent validation of
selected DEGs was performed by quantitative real-time PCR as
described below.
Quantitative Real-Time RT-PCR Analyses
mRNA levels were quantiﬁed by TaqMan qRT-PCR (CFX384 real-
time system, Bio-Rad Laboratories) using the iScript 1-step RT-
PCR kit for probes (Bio-Rad Laboratories) (see Supplementary
Information). Relative target gene expression was calculated
according to the 2(-Delta Delta C(T)) method. Probe and primer
sequences of Claudin11 (Assay: Mm00500915_m1) were pur-
chased from Life Technologies (Switzerland), while the custom
designed probe and primer sequences used for MOBP, MOG,
MAL and MAG are summarized in Supplementary Table 1 and
were purchased from Euroﬁns Genomics GmbH (Germany).
DNA Methylation Analysis
DNA methylation levels of the α-myelin-associated oligodendrocy-
tic basic protein (MOBP) promoter region were quantiﬁed using the
EpiTYPER assay. This technique detects and quantiﬁes DNA
methylation using base-speciﬁc cleavage and Matrix-Assisted
Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spe-
ctrometry (Suchiman et al. 2015). Genomic DNA was treated and
analysed as fully described in the Supplementary Information.
Brain Sample Preparation for MRI
At 12 weeks of age, CON and POL offspring from the second
cohort were deeply anaesthetized with an overdose of Nembu-
tal (Abbott Laboratories) and perfused transcardially with 0.9%
Prenatal Infection and Myelination-Related Deﬁcits Richetto et al. | 3
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NaCl, followed by 4% phosphate-buffered paraformaldehyde
(PFA) solution containing 15% picric acid (Giovanoli et al. 2013).
After perfusion, the animals were decapitated and the skin,
lower jaw and ears were removed. The brain within the skull
was incubated in 4% PFA overnight at +4°C and then shipped to
King’s College London the next day. Upon arrival, brain sam-
ples were transferred to 0.01M phosphate-buffered saline con-
taining and 0.05% sodium azide for at least 7 days prior to MR
imaging.
MRI acquisition, Processing and Analysis
A 7T horizontal small bore magnet and (Agilent Technologies
Inc. Santa Clara, USA) and a quadrature volume radiofrequency
coil (39 mm internal diameter, Rapid Biomedical GmbH) were
used for all MRI acquisitions. Fixed brain samples were placed
securely up to 4 at a time in an MR-compatible holder and
immersed in proton-free susceptibility matching ﬂuid
(FluorinertTM FC-70; Sigma-Aldrich, UK). The following MR
images were acquired: T2-weighted 3D Fast Spin-Echo (FSE) and
a multicomponent Driven Equilibrium Single Pulse Observation
of T1 and T2 (mcDEPSOT) protocol with B1 correction. The latter
consists of a Spoiled Gradient echo (SPGR), balanced Steady
State Free Procession (bSSFP) and Actual Flip-angle imaging
(AFI) scans (Deoni et al. 2013). The mcDESPOT protocol gener-
ates data to calculate parametric maps of T1, T2, and the myelin
water fraction (MWF) for each animal (Supplementary Figure 1).
Parameters for each scan are summarized in Supplementary
Table 3. MR image processing and analysis were performed as
fully described in the Supplementary information.
Group-level differences in MRI parameters (volume, T1, T2,
and MWF) between CON and POL offspring were analysed
voxel-wise across the whole-brain using permutation testing
and threshold free cluster enhancement (TFCE) implemented
in FSL Randomize (Smith and Nichols 2009) and corrected for
multiple comparisons using the false discovery rate (FDR)
(Genovese et al. 2002) at q = 0.05. For volume, comparisons
were made between CON (N = 10) and POL (N = 10) offspring.
For mcDESPOT data, comparisons were made between CON
(N = 6) and POL (N = 8) offspring, as 4 scans from the CON group
and 2 scans from the POL group had to be discarded due to
artefacts in the data (see Supplementary Information).
Immunohistochemistry
After completion of all MRI, ﬁxed brain tissues were processed
for immunohistochemical analyses as described in the
Supplementary information. Standard immunohistochemical
procedures were implemented to stain for α-myelin basic
protein (MBP; rabbit anti-MBP; Abcam, Cat no. ab7349; diluted
1:1000) and MOBP (rabbit anti-MOBP; Abcam, Cat no. ab2033
88; diluted 1:500) as fully described in the Supplementary
information.
Threshold Image Analysis for Myelin Staining
Quantitative analyses of MBP and MOBP-positive staining were
performed in the mPFC using unbiased threshold image ana-
lysis as described in the Supplementary Information. All post-
processing and analysis was performed using ImageJ software
(http://imagej.nih.gov/ij/). The percentage area of immunoposi-
tive pixels in each acquired image of the mPFC, from 4 consecu-
tive sections, were averaged to give a single value per animal.
Statistical Analyses
All behavioral and RT-PCR were analysed using independent
Student’s t-tests (2-tailed). Immunohistochemical analysis was
conducted using a 1-tailed Student’s T-test, given the a-priori
hypothesis based on the strong gene expression data. Statis-
tical signiﬁcance was set at P < 0.05 for these analyses. Micro-
array and MRI data were analysed as described above. DNA
methylation levels measured using EpiTYPER were analysed
using repeated-measures analysis of variance (RM-ANOVA) fol-
lowed by Fisher’s least signiﬁcant difference (FLSD) post hoc
comparisons whenever appropriate. Correlative analyses
between the dependent measures of primary interest (behav-
ioral and cognitive data, mRNA and DNA methylation data, MRI
data, and immunohistochemical data) were performed using
ﬁrst-order partial correlations partialling for the 2 prenatal
treatment conditions. Hence, partial correlations were used to
control for the effects of the independent variable “prenatal
immune activation”. All statistical analyses were performed
using the statistical software SPSS (v22.0; IBM Corporation,
Armonk, New York, USA).
Results
Prenatal immune activation induces deﬁcits in short-
term spatial recognition memory and social interaction
First, we aimed to ascertain the effects of prenatal immune
activation on adult behavioral and cognitive functions. We
found that POL offspring displayed impaired performance in a
Y-maze spatial recognition memory test. (Fig. 1A). In this test,
the critical measure of spatial recognition memory is the rela-
tive time spent in the novel (previously unexplored) arm during
the choice phase. CON offspring displayed a noticeable prefer-
ence towards the novel arm, indicating intact spatial recogni-
tion memory in these groups (Fig. 1A). In contrast, POL
offspring exhibited a marked reduction (P < 0.05) in this meas-
ure and performed only at chance level (Fig. 1A). There were no
group differences with respect to the total distance moved
(Fig. 1A), indicating that the negative effects of prenatal
immune activation on spatial recognition memory are not con-
founded by possible differences in basal locomotor activity.
POL offspring also displayed impaired marked deﬁcits in the
social interaction test, in which they were ﬁrst allowed to con-
comitantly explore an inanimate dummy object and an unfamil-
iar live mouse (Fig. 1B). During this phase of the test, CON
offspring showed a clear preference (>65%) for the live mouse
versus the inanimate dummy object (Fig. 1B). By contrast, POL
offspring did not display such a preference (Fig. 1B), indicating
reduced sociability towards unfamiliar conspeciﬁcs. This led to a
signiﬁcant (P < 0.001) group difference in the percent time spent
with the live mouse (Fig. 1B).
To test social recognition memory, the inanimate dummy
object was then replaced by another unfamiliar live mouse, and
the relative exploration time between the previously explored
and novel live mouse was measured. During this phase of the
social interaction test, CON offspring showed a clear preference
(>65%) for the novel mouse (Fig. 1B). POL offspring did not dis-
play such a preference, leading to a signiﬁcant (P < 0.05) group
difference in the percent time spent with the novel mouse
(Fig. 1B). In both phases of the social interaction test, there
were no group differences with respect to the total distance
moved. Hence, prenatal immune activation leads to genuine
deﬁcits in social approach behavior and short-term spatial
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recognition memory without concomitant effects on general
exploratory behavior.
Prenatal immune activation alters the long-term
transcription proﬁle of the medial prefrontal cortex and
nucleus accumbens
As shown in Figure 2A, which represents the hierarchical clus-
tering of expression changes induced by prenatal infection with
poly(I:C), 116 genes were differentially expressed in the mPFC
(fold change cut-off: ± 1.2; P < 0.05), while 251 were differentially
expressed in the NAc. Of the 116 genes that were differentially
expressed in the mPFC, 55 were downregulated and 61 were
upregulated (Tables 1 and 2), while in the NAc, 126 were down-
regulated and 125 upregulated (Tables 3 and 4). Interestingly,
many of these have been already associated with schizophre-
nia, such as adenosine 2a receptor (ADORA2a), apolipoprotein
D (APOD), the dopamine receptors DRD2 and DRD3, forkhead box
P2 (FOXP2), glutaminase (GLS), the glutamate receptor subunit
GRIN2A, histone cluster 1 (HIST1H2BC), 5-hydroxytryptamine
receptors (HTR1A, HTR2A, HTR4), oxytocin (OXT), solute carriers
(SLC17A7), and, among others, vescicle-associated membrane
protein 4 (VAMP4) (Butler et al. 2016). A Gene Ontology (GO)
enrichment analysis computing the DEGs in the mPFC and NAc
is presented in Supplementary Table 2.
Next, the genes affected in both brain areas were compared.
As shown in Figure 2B, the Venn diagram of the 2 brain areas
highlighted 14 common genes, 11 of which are modulated in
the same direction in both brain areas (Fig. 2B). In particular,
poly(I:C) exposure affected the expression of 6 main genes
involved in myelination, both in the mPFC and in the NAc:
myelin and lymphocyte protein (MAL), myelin-associated
glycoprotein (MAG), myelin-associated oligodendrocytic basic
protein (MOBP), myelin oligodendrocyte glycoprotein (MOG),
claudin 11 (Cldn11), and myelin regulatory factor (Myrf). The
Figure 1. Cognitive and behavioral deﬁcits following late prenatal immune acti-
vation. Mice were subjected to prenatal poly(I:C) treatment on gestation day 17
(POL), or they were exposed to prenatal control (CON) treatment. (A) Percent
time spent in the novel arm during the Y-maze working memory test. *P < 0.05
based on independent Student’s t tests (2-tailed). (B) Percent time spent with an
unfamiliar live mouse, relative to an inanimate dummy object, during the
social interaction test; and percent time spent with a novel live mouse, relative
to a familiar one, during the social recognition test. *P < 0.05 and ***P < 0.001
based on independent Student’s t tests (2-tailed). All data are based on N
(CON) = 10, N(POL) = 10 and represent means ± s.e.m.
Figure 2. Unique and common gene expression differences following late pre-
natal immune activation in the mPFC and NAc, revealed by microarray. Mice
were subjected to prenatal poly(I:C) treatment on gestation day 17 (POL), or
they were exposed to prenatal control (CON) treatment. (A) Hierarchical cluster-
ing of differentially expressed genes in POL offspring relative to CON offspring
in the mPFC and NAc. Down- and upregulated genes are represented in purple
and yellow color, respectively. (B) Venn Diagram depicting the number of genes
that are uniquely and commonly affected in the mPFC and NAc of POL off-
spring. The commonly affected genes are listed for each brain area, with down-
and upregulated genes being represented by blue and red color, respectively.
All data are based on N(CON) = 6, N(POL) = 6.
Prenatal Infection and Myelination-Related Deﬁcits Richetto et al. | 5
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ﬁrst 5 of these, which were found to be downregulated by poly
(I:C) in the gene array analysis, resulted decreased by the pre-
natal manipulation also when analysed with real-time qRT-
PCR (Fig. 3A). Ingenuity Pathway analysis (Fig. 3B) and GO
Table 1 The table represents the 55 downregulated genes in the mP-
FC as revealed by microarray. All data are based on N(CON) = 6, N
(POL) = 6
Gene Fold change P-value
Adamts4 −1.259 0.00291
Adora2a −1.260 0.02701
Adra2a −1.222 0.01440
Bcas1 −1.242 0.00095
Cabp7 −1.232 0.03128
Cdca7 −1.225 0.00062
Cldn11 −1.356 0.00088
Clic4 −1.216 0.00030
Cnp −1.265 0.00317
Cpm −1.215 0.00897
Cryge −1.657 0.04590
Cyp2j12 −1.215 0.00246
Cyp4a28-ps −1.330 0.00077
Dlk1 −1.215 0.03507
Dnali1 −1.205 0.00218
Drd2 −1.453 0.03478
Fa2h −1.297 0.01749
Galnt6 −1.259 0.00046
Gas5 −1.721 0.00002
Glp1r −1.360 0.02303
Gpr6 −1.405 0.01594
Gstm6 −1.241 0.01346
Hist1h2bb −1.269 0.00025
Hist1h2bq −1.202 0.00064
Lrrc10b −1.273 0.00186
Mag −1.261 0.01173
Mal −1.312 0.00395
Mobp −1.417 0.00124
Mog −1.250 0.02082
mt-Ta −3.146 0.00019
mt-Tq −1.253 0.02654
mt-Tv −1.322 0.01354
Myrf −1.229 0.00307
Nnat −1.266 0.00510
Nxph3 −1.211 0.02714
Opalin −1.333 0.02207
Pcp4l1 −1.204 0.02124
Ppp1r1b −1.205 0.00369
Prelp −1.209 0.01465
Rem2 −1.203 0.00109
Rny1 −1.558 0.00612
Rpl7a −1.207 0.00078
Rps27rt −1.206 0.00008
Rybp −1.205 0.00002
Sf3b4 −1.234 0.01561
Shisa6 −1.216 0.00798
Sox4 −1.231 0.00129
Thbs4 −1.455 0.00133
Trf −1.235 0.00786
Tspan2 −1.236 0.00875
Txnip −1.210 0.04400
Ube2v1 −1.237 0.00744
Ugt8a −1.203 0.02783
Zcchc12 −1.213 0.01511
Zic1 −1.301 0.03720
Table 2 The table lists the 61 upregulated genes in the mPFC as rev-
ealed by microarray. All data are based on N(CON) = 6, N(POL) = 6
Gene Fold change P-value
Aak1 1.212 0.00227
Adamts10 1.217 0.00008
Atp11b 1.300 0.00070
BC005561 1.221 0.00146
BC030499 1.493 0.00080
Cdh12 1.218 0.00004
Chuk 1.202 0.00032
Coro6 1.318 0.00003
Cpne9 1.223 0.00090
Cspp1 1.234 0.00005
Ddx26b 1.267 0.00126
Dnajc13 1.212 0.00141
Echdc2 1.238 0.01081
Eif2s3y 1.446 0.02942
Eml5 1.234 0.00236
Fam178a 1.236 0.00081
Fat3 1.276 0.00084
Fcf1 1.209 0.00307
Firre 1.204 0.04499
Flnb 1.221 0.00683
Gpatch8 1.287 0.00472
Gtf3c2 1.209 0.01987
Herc6 1.244 0.00051
Hnrnpu 1.463 0.00304
Kansl1 1.348 0.01338
Leng8 1.372 0.00557
Luc7l3 1.220 0.00244
Malat1 1.343 0.01141
Meg3 1.312 0.00568
Mirg 1.398 0.00012
mt-Ty 1.251 0.00880
Myo9a 1.244 0.00058
Npas4 1.587 0.01846
Nup93 1.239 0.00071
Nvl 1.246 0.00027
Paxbp1 1.225 0.00141
Phf20l1 1.232 0.01339
Pisd-ps1 1.240 0.02393
Pisd-ps2 1.206 0.00064
Pnet-ps 1.290 0.01531
Pnisr 1.332 0.00103
Prpf39 1.299 0.00094
Rbm12b2 1.238 0.00561
Rbm33 1.318 0.00284
Rnpc3 1.321 0.00096
Rps6kb2 1.225 0.00088
Rxfp1 1.211 0.00002
Sfswap 1.218 0.00018
Slc9b2 1.221 0.00003
Smpd4 1.262 0.00036
Snhg11 1.269 0.00258
Taf1d 1.228 0.00118
Tfrc 1.205 0.00033
Tmem181a 1.246 0.00040
Trank1 1.340 0.00047
Ttc14 1.364 0.00064
Uggt2 1.381 0.00061
Vmn2r84 1.307 0.00099
Vmn2r86 1.578 0.00221
Wsb1 1.243 0.00812
Zcchc7 1.235 0.00203
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Table 3 The table lists the 126 downregulated genes in the NAc as
revealed by microarray. All data are based on N(CON) = 6, N(POL) = 6
Gene Fold change P-value
Agt −1.733 0.0412
Ankub1 −1.333 0.0261
Anln −1.293 0.0299
Apod −1.226 0.0014
Arhgdib −1.300 0.0182
Arsg −1.248 0.0006
Aspa −1.352 0.0117
Atp13a4 −1.210 0.0284
BC005624 −1.204 0.0000
Bcas1 −1.250 0.0009
Cacng4 −1.226 0.0154
Calml4 −1.267 0.0372
Capsl −1.353 0.0452
Ccdc170 −1.222 0.0401
Cd63 −1.298 0.0066
Cd82 −1.343 0.0055
Cdhr3 −1.379 0.0424
Chd6 −1.207 0.0247
Chd7 −1.215 0.0308
Cldn10 −1.213 0.0073
Cldn11 −1.227 0.0028
Clmn −1.243 0.0309
Cobl −1.216 0.0254
Coch −1.378 0.0081
Crabp1 −1.296 0.0034
Cspp1 −1.255 0.0247
Ctnna1 −1.221 0.0016
Cyp2j9 −1.270 0.0019
Dnah3 −1.358 0.0258
Ebf1 −1.330 0.0005
Ebf2 −1.267 0.0446
Ebf3 −1.321 0.0181
Edil3 −1.210 0.0134
Eif3e −1.250 0.0011
Elovl7 −1.343 0.0338
Enpp2 −1.691 0.0318
Ephx1 −1.209 0.0028
Evi2a −1.246 0.0064
Fmo1 −1.219 0.0106
Frem3 −1.213 0.0017
Gab1 −1.210 0.0021
Gal −2.353 0.0002
Galr1 −1.307 0.0126
Glis3 −1.255 0.0121
Gpr37 −1.293 0.0084
Gstm6 −1.225 0.0242
Hist1h1c −1.409 0.0002
Hist1h2bc −1.265 0.0036
Hmcn1 −1.236 0.0018
Iqcg −1.300 0.0422
Iqcj −1.209 0.0017
Itpkb −1.270 0.0449
Kif6 −1.206 0.0040
Mag −1.241 0.0223
Mal −1.318 0.0013
Meig1 −1.416 0.0274
Mgst1 −1.266 0.0023
Mobp −1.423 0.0000
Mog −1.263 0.0121
Mpeg1 −1.293 0.0007
mt-Tf −1.233 0.0018
(Continued)
Table 3 (Continued)
Gene Fold change P-value
mt-Tn −1.591 0.0033
Mtx2 −1.209 0.0123
Myrf −1.313 0.0009
Ndrg1 −1.237 0.0083
Nhp2 −1.331 0.0112
Nme5 −1.241 0.0096
Nr2f2 −1.698 0.0014
Nsmce4a −1.232 0.0010
Opalin −1.480 0.0015
Oxt −1.322 0.0018
Pcolce2 −1.338 0.0081
Pde8a −1.223 0.0056
Phldb1 −1.247 0.0013
Pigk −1.203 0.0018
Pir −1.218 0.0032
Pld1 −1.210 0.0284
Pllp −1.301 0.0011
Prlr −2.081 0.0194
Prox1 −1.400 0.0171
Prr18 −1.224 0.0049
Prrg4 −1.267 0.0325
Psma1 −1.200 0.0039
Rarres2 −1.234 0.0476
Rassf2 −1.270 0.0008
Rdm1 −1.675 0.0130
Rgs10 −1.238 0.0101
Rgs3 −1.292 0.0011
Ror1 −1.233 0.0250
Rpl26 −1.264 0.0036
Rpl35a −1.212 0.0126
Rpl36 −1.203 0.0054
S1pr5 −1.252 0.0037
Scarna13 −1.446 0.0097
Sccpdh −1.275 0.0102
Sgms2 −1.253 0.0221
Shank2 −1.478 0.0088
Slirp −1.269 0.0115
Smco3 −1.234 0.0137
Sorcs1 −1.228 0.0014
Sparc −1.289 0.0360
Spef2 −1.474 0.0195
St6galnac1 −1.222 0.0006
Stxbp3a −1.258 0.0001
Synpo2 −1.308 0.0016
Tac2 −2.333 0.0005
Tcf7l2 −1.341 0.0309
Tcn2 −1.223 0.0208
Tm4sf1 −1.225 0.0454
Tmbim1 −1.235 0.0033
Tmem212 −1.250 0.0335
Tmem215 −1.215 0.0010
Tnfaip6 −1.236 0.0133
Trdn −1.242 0.0017
Trh −1.303 0.0038
Ttc21a −1.221 0.0254
Ttr −7.075 0.0118
Unc13c −1.275 0.0141
Vamp4 −1.315 0.0003
Vps4b −1.219 0.0005
Wdr49 −1.286 0.0091
Wdr63 −1.205 0.0120
(Continued)
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Table 3 (Continued)
Gene Fold change P-value
Wdr96 −1.228 0.0156
Whrn −1.278 0.0360
Zbtb10 −1.209 0.0080
Zfhx3 −1.217 0.0384
Table 4 The table lists the 125 upregulated genes in the NAc as rev-
ealed by microarray. All data are based on N(CON) = 6, N(POL) = 6
Gene Fold change P-value
Adamts3 1.325 0.0018
Adat3 1.235 0.0168
Adh5 1.202 0.0049
Ahr 1.234 0.0005
Ankrd45 1.275 0.0001
Apbb3 1.215 0.0003
Arpc5 1.206 0.0437
Azin1 1.288 0.0002
B3galt2 1.443 0.0164
Bcl11a 1.203 0.0393
Bmp3 1.292 0.0488
Brinp2 1.225 0.0127
Btbd3 1.238 0.0163
Cabp7 1.270 0.0108
Cacna2d1 1.325 0.0091
Cacnb3 1.210 0.0270
Cckbr 1.371 0.0399
Cecr6 1.226 0.0433
Clec2l 1.226 0.0088
Cnih3 1.455 0.0174
Cntnap3 1.270 0.0394
Col6a1 1.329 0.0023
Crebbp 1.201 0.0001
Csgalnact1 1.325 0.0034
Ctgf 1.664 0.0466
Dab1 1.221 0.0143
Dclk3 1.218 0.0219
Dkk3 1.216 0.0188
Drd3 1.507 0.0005
Dsg1a 1.277 0.0003
Dsg1c 1.242 0.0012
Echdc2 1.200 0.0246
Eri2 1.293 0.0148
Fam131a 1.388 0.0041
Fgf10 1.230 0.0139
Foxp2 1.215 0.0144
Galnt9 1.326 0.0261
Gls 1.287 0.0120
Gnrh1 1.272 0.0243
Gpr126 1.277 0.0066
Gpr149 1.284 0.0203
Gpr26 1.355 0.0138
Grin2a 1.262 0.0381
Gtpbp2 1.204 0.0003
Gtpbp8 1.322 0.0397
Hmgcr 1.215 0.0216
Hsd17b7 1.262 0.0254
Hspbp1 1.233 0.0250
Htr1a 1.387 0.0264
Htr2a 1.360 0.0410
Htr4 1.316 0.0019
(Continued)
Table 4 (Continued)
Gene Fold change P-value
Igsf21 1.322 0.0290
Islr2 1.319 0.0137
Itpka 1.231 0.0086
Kcnab3 1.251 0.0096
Kcnh3 1.232 0.0390
Kctd16 1.247 0.0410
Kifc2 1.231 0.0029
Lix1 1.270 0.0084
Lmo4 1.201 0.0011
Lrrc55 1.318 0.0065
Mafg 1.205 0.0026
Mef2c 1.304 0.0214
Mef2d 1.287 0.0040
Mgll 1.267 0.0019
Morn4 1.201 0.0087
Mpped1 1.331 0.0295
Myo16 1.345 0.0017
Napb 1.232 0.0460
Ndnf 1.341 0.0403
Ndufa13 1.201 0.0015
Nmbr 1.776 0.0373
Nov 2.691 0.0160
Npas4 1.574 0.0214
Nptx1 1.645 0.0140
Npy1r 1.303 0.0316
Ntn1 1.291 0.0062
Nxph3 1.302 0.0295
Ociad2 1.265 0.0208
Olfm3 1.248 0.0229
Pbrm1 1.228 0.0279
Pcsk5 1.229 0.0020
Pdcd4 1.213 0.0236
Pde1a 1.341 0.0028
Pdyn 1.251 0.0358
Pls3 1.211 0.0446
Pou3f4 1.201 0.0369
Ppp1r12b 1.234 0.0074
Prr14l 1.238 0.0214
Rap1gap2 1.207 0.0301
Rapgeﬂ1 1.337 0.0103
Rasl10b 1.215 0.0222
Rfk 1.237 0.0258
Rnf26 1.217 0.0257
Rnf39 1.267 0.0059
Satb1 1.274 0.0366
Sema5b 1.235 0.0107
Sidt1 1.432 0.0278
Slc17a7 2.840 0.0490
Slc2a3 1.242 0.0018
Slc7a4 1.224 0.0016
Slco5a1 1.234 0.0030
Slit2 1.279 0.0420
Sprn 1.263 0.0206
Spryd3 1.205 0.0266
St3gal1 1.619 0.0005
Stard5 1.685 0.0063
Stra6 1.396 0.0103
Strip2 1.239 0.0427
Sult4a1 1.299 0.0106
Svop 1.232 0.0070
Szt2 1.283 0.0013
(Continued)
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enrichment analyses (Supplementary Table 2) suggested that
these genes are implicated in a variety of biological processes
and functions implicated in myelination and ensheathment of
axons.
We further sought evidence for the possibility that changes
in the expression of myelin-related genes would correlate with
the behavioral and cognitive performance. In support of this
notion, we found that the mRNA levels of MOG in the mPFC
correlated positively with the animals’ performance in the spa-
tial recognition memory test (Supplementary Table 3). On the
other hand, the gene expression levels of MOG, MAG, MAL and
MOBP in the NAc showed a marked positive correlation with
social approach behavior (Supplementary Table 6).
Whole-brain, voxel-wise macroscale MRI phenotyping
of immune-challenged and control offspring
At 12 weeks of age, total brain volume did not signiﬁcantly dif-
fer between behaviorally naïve CON (572 ± 7mm3) and POL off-
spring (584 ± 3mm3). Voxel-wise TBM analysis revealed sparse
neuroanatomical differences in relative volume between the
2 groups (q = 0.05 FDR corrected; Fig. 4). Biologically plausible
clusters of voxels showing apparent volume increases were
present in the right hemisphere in the primary motor, som-
atosensory cortex (barrel ﬁeld) and visual cortex (Fig. 4). In
contrast, biologically plausible clusters of voxels showing
apparent volume decreases were present bilaterally in the piri-
form cortex, anterior commissure, interfasicular nucleus,
third ventricle, left periaqueductal gray nucleus, left external
capsule, extending into the left ﬁmbria, right amygdala and
the right ventral mesencephalon (Fig. 4). Interestingly, the
cerebellum showed the most pronounced volumetric altera-
tions in POL offspring. Apparent volume increases were pre-
sent in the crus 1 of the ansiform lobule and simple lobule and
the inferior cerebellar peduncles (Fig. 4). In contrast, apparent
volume decreases were present in the ﬁfth cerebellar lobule,
right paraﬂocculus and paramedian lobule of the cerebellum
(Fig. 4).
We next tested for the presence of group-level differences
between CON and POL offspring in the tissue parameters
derived from the mcDESPOT dataset. Brain-wide voxel-wise
cluster analysis revealed little or no change in T1, although
sparse, but biologically plausible clusters of increased T1 (spin-
lattice) relaxation time (+100ms) were present bilaterally in the
anterior nucleus accumbens and the inferior cerebellar peduncles
(q = 0.05 FDR corrected; Fig. 5A). In contrast, T2 (spin–spin)
relaxation times were signiﬁcantly decreased in POL offspring
(−20ms) in the prefrontal, anterior cingulate, insular, retros-
plenial granular, motor, somatosensory, visual and auditory
Table 4 (Continued)
Gene Fold change P-value
Tenm4 1.233 0.0027
Tmem132d 1.205 0.0456
Tmem160 1.317 0.0015
Tmem56 1.206 0.0439
Tpbg 1.215 0.0085
Trim23 1.254 0.0175
Tsnax 1.245 0.0001
Ttc39b 1.234 0.0325
Ube3b 1.224 0.0018
Uck2 1.220 0.0160
Uqcrc1 1.251 0.0000
Wdr54 1.258 0.0008
Wnt2 1.286 0.0051
Figure 3. Validation of commonmyelin-related gene expression differences in the
mPFC and NAc. Mice were subjected to prenatal poly(I:C) treatment on gestation
day 17 (POL), or they were exposed to prenatal control (CON) treatment .(A) The
bar plots represent the mRNA levels of each selected gene (% versus CON). The
gene expression levels were assessed by RT-qPCR. *P < 0.05, **P < 0.01 and
***P < 0.001 based on independent Student’s t tests (2-tailed). All data are based on
N(CON) = 10, N(POL) = 10 represent means ± s.e.m. (B) Graphical representation of
the network analysis conducted on the commonly affected myelin genes. The
analysis was conducted using Ingenuity Pathway Analysis (IPA), and each gene is
represented in relation to the others and to the speciﬁc functions it is involved in.
1 = Ensheathment of axons; 2 = Myelination; 3 = Myelination of cells;
4 =Myelination of nerves; 5 = Dendritic growth and branching.
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cortices, with stronger decreases (−40ms) in the piriform cortex
(q = 0.05 FDR corrected; Fig. 5B). Bilateral decreases in T2 (−20ms)
were also present in the hypothalamus, ventral thalamus, dor-
sal, and ventral hippocampus, ventral mesencephalon and cere-
bellar gray and white matter, respectively (Fig. 5B).
Myelin water fraction (MWF) increased signiﬁcantly in POL
as compared to CON offspring, particularly in the cortex, hippo-
campus, and cerebellar gray and white matter (q = 0.05 FDR cor-
rected; Fig. 5C). These increases ranged from +2% in the
prefrontal cortex to +7% in the cerebellum (Fig. 5C). Notably,
increases in MWF largely overlapped with the topographical
distribution of decreases in T2, but not T1.
Prenatal immune activation affects protein expression
levels of MOBP
Based on the preceding ﬁndings, we sought to verify whether
the myelination-related changes in gene expression and MRI
translate into, and stem from, differential protein expression.
Thus, we analysed the protein levels of MBP, a major constitu-
ent of the myelin sheath, and MOBP, one of the candidates that
emerged from our genome-wide study, with immunohisto-
chemistry and optical densitometry (OD) in mPFC. Consistent
with our gene expression study, but not the apparent increase
in MWF in the MR images, there were no signiﬁcant differences
Figure 4. Sparse alterations in neuroanatomy following late prenatal immune activation revealed by brain-wide tensor based morphometry analysis of 3D FSE T2-
weighted MR images. Mice were subjected to prenatal poly(I:C) treatment on gestation day 17 (POL; N = 10), or they were exposed to prenatal control (CON, N = 10)
treatment. Data shown are signiﬁcant group-level voxel-wise differences in the scaled log Jacobian determinant (corrected for total brain volume) thresholded at
q < 0.05 (FDR-corrected). Distances from bregma are indicated in mm for each slice shown. R, right; L, left; S, superior; I, inferior.
Figure 5. Alterations in (A) T1, (B) T2 relaxation time, and (C) myelin water fraction (MWF) following late prenatal immune activation as revealed by voxel-wise cluster
analysis. Mice were subjected to prenatal poly(I:C) treatment on gestation day 17 (POL; N = 8), or they were exposed to prenatal control (CON; N = 6) treatment. Data
shown are the signiﬁcant voxel-wise changes in each tissue parameter relative to the control group thresholded at q < 0.05 (False discovery rate corrected). Distances
from bregma are indicated in mm for each slice shown. R, right; L, left; S, superior; I, inferior. Changes in the medial prefrontal cortex (mPFC) and nucleus accumbens
(NAc) are highlighted by the symbol (*).
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in the area fraction of MBP-immunoreactive pixels in the mPFC
of POL relative to CON offspring (Fig. 6A). In contrast, the area
fraction of MOBP-immunoreactive pixels was reduced in the
mPFC of POL relative to CON offspring (Fig. 6B).
Relationships between MRI and postmortem histology
Correlative analyses revealed a signiﬁcant negative correlation
between MWF (%) and T2 (ms) in the prefrontal cortex of CON
offspring, such that longer T2 relaxation times were associated
with smaller MWF (Supplementary Figure 2). These data are in
good agreement with relaxometry studies in dys-myelinated
mice (Shiverer mutants), which show extended T2 relaxation
times relative to their WT littermates (Dyakin et al. 2010) and
our prior work in the cuprizone mouse model (Wood et al.
2016a, 2016b). T2 relaxation time is also reported to correlate
with MWF values in human datasets, although these relation-
ships appear to be inconsistent (positive and negative) over dif-
ferent developmental periods (Deoni et al. 2012). A strong trend
for the same relationship was also present in POL offspring
(Supplementary Figure 2). There were no other signiﬁcant cor-
relations between MRI parameters (T1, T2, MWF, or volume) in
either CON or POL offspring (data not shown).
We next investigated relationships between the values of T1,
T2, and MWF against the area fraction of MBP and MOBP stain-
ing in the mPFC, where these data were available for the same
Figure 6. Immunohistochemical alterations following late prenatal immune activation. Mice were subjected to prenatal poly(I:C) treatment on gestation day 17 (POL),
or they were exposed to prenatal control (CON) treatment. (A) The photomicrographs show representative staining of myelin basic protein (MBP) (scale bar = 50 µm),
and the bar plots represent the percent area of immunoreactive pixels for MBP. N(CON) = 10, N(POL) = 9. (B) The photomicrographs show representative staining of
myelin-associated oligodendrocyte basic protein (MOBP) (scale bar = 20 µm), and the bar plots represent the percent area of immunoreactive pixels for MOBP.
*P = 0.041, N(CON) = 7 and N(POL) = 8. All data represent means ± s.e.m.
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animal. The results of this analysis are presented in
Supplementary Table 9. We found no signiﬁcant relationship
between the measured MWF and MBP area fraction in either
CON or POL offspring. In contrast, a signiﬁcant negative correl-
ation was found between T2 and MOBP area fraction in the
mPFC of POL offspring, such that shorter T2 values were asso-
ciated with a greater area fraction of MOBP (Supplementary
table 9). The T1 values in the mPFC were also negatively related
to MOBP area fraction in POL offspring, although this failed to
reach statistical signiﬁcance at the 2-tailed level (r = −0.739;
P = 0.09; Supplementary Table 9)
Prenatal immune activation alters the methylation
proﬁle of the MOBP promoter
We were further interested in examining whether epigenetic
modiﬁcations may be a plausible mechanism underlying the
transcriptional effects of prenatal immune activation. To test
this hypothesis, we analysed DNA methylation proﬁles of the
MOBP promoter in the mPFC and NAc using the EpiTYPER tech-
nique, which detects and quantiﬁes DNA methylation using
MALDI-TOF mass spectrometry (Suchiman et al. 2015). We
focused on MOBP because the initial microarray and subse-
quent RT-PCR analyses consistently revealed decreased expres-
sion of this myelination-related gene in offspring exposed to
prenatal immune activation relative to control offspring (Figs
2A and 3A).
We found hypermethylation of multiple CpGs sites in 2 dis-
tinct MOBP promoter segments that are adjacent to (amplicon
1) or incorporate (amplicon 2) the transcriptional start site (TSS)
(Fig. 7). In the mPFC, the infection-induced changes in CpG
methylation levels differed as a function of genomic location:
The percent CpG methylation encompassed in amplicon 1 was
increased at CpG507 and CpG457 in POL compared to CON off-
spring, whereas it was decreased at CpG343 in the former rela-
tive to the latter group (Fig. 7B). On the other hand, the CpG
sites encompassed in amplicon 2 were generally hypermethy-
lated in POL relative to CON offspring (Fig. 7B). Prenatal
immune activation also led to genomic location-dependent
changes in accumbal MOBP DNA methylation: the methylation
levels at CpG239 (amplicon 1) and at CpG210 (amplicon 2) were
increased in POL compared to CON offspring (Fig. 7C).
We further investigated whether the infection-induced
changes in DNA methylation might correlate with the gene
expression levels of MOBP and with the animals’ behavioral
performance. As summarized in Supplementary Table 4 and
Supplementary Table 5, the methylation levels of CpG457 posi-
tively correlated with the expression levels of MOBP in the
mPFC, whereas the methylation levels of CpG343 negatively cor-
related with the animals’ performance in the spatial recogni-
tion memory test. There were no signiﬁcant correlations
between MOBP DNA methylation and gene expression levels in
the NAc, nor were there any signiﬁcant correlations between
accumbal DNA methylation and behavioral performances of
primary interest (Supplementary Table 7 and 8).
Figure 7. Investigation of DNA methylation differences in the promoter of the MOBP gene using EpiTYPER. Mice were subjected to prenatal poly(I:C) treatment on ges-
tation day 17 (POL), or they were exposed to prenatal control (CON) treatment. (A) Graphical representation of the MOBP gene and genomic locations of the selected
amplicons. Sequences of the selected amplicons and position of investigated CpGs in each amplicon. Methylation of the numbered CpGs (in bold font) was accessible
to quantiﬁcation by EpiTYPER, whereas underlined CpGs were un-measurable for technical reasons. (B) Percent DNA methylation of speciﬁc CpGs in the medial pre-
frontal cortex. Amplicon 1: *P < 0.05, based on post hoc comparisons at each individual CpG site following the presence of a signiﬁcant interaction between prenatal
treatment and CpG region (F(6,54) = 5.35, P < 0.001); amplicon 2: *P < 0.05, reﬂecting the signiﬁcant main effects of prenatal treatment (F(1,9) = 7.32, P < 0.05). (C) Percent
DNA methylation of speciﬁc CpGs in the nucleus accumbens. *P < 0.05, based on post hoc comparisons at each individual CpG site following the presence of a signiﬁ-
cant interaction between prenatal treatment and CpG region (amplicon 1: F(6,54) = 2.52, P < 0.05; amplicon 2: F(3,27) = 2.45, P < 0.05). All data are based on N(CON) = 6
and N(POL) = 5 and reﬂect means ± s.e.m.
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Discussion
The present study analysed the gene expression proﬁles of the
mPFC and NAc following exposure to late prenatal immune
activation, and implemented a multi-system approach based
on MR imaging, immunohistochemistry and epigenetic ana-
lyses to follow-up the gene expression changes it uncovered.
Late prenatal immune activation led to a dysregulation of a
variety of different genes in both brain areas, and to common
prefrontal and striatal changes in myelin markers of function-
ality and stability. These ﬁndings were conﬁrmed and extended
by MRI and immunohistochemical results, while epigenetic
analyses pointed to altered DNA methylation as a putative
molecular mechanism underlying some of the transcriptional
effects. Our study thus adds to the characterization of the long-
lasting molecular signatures of late prenatal immune activation
in adult corticostriatal regions.
Our transcriptomic and epigenetic analyses in immune-
challenged and control offspring were conducted using behav-
iorally and cognitively characterized animals. Advantages of
this approach include that the examination of possible molecu-
lar effects takes place against the background of overt behav-
ioral and cognitive phenotypes, which appears particularly
important for (immune-mediated) neurodevelopmental disrup-
tion models that may contain a certain degree of litter-to-litter
variability (Meyer et al. 2009). Here, we conﬁrmed the deleteri-
ous effects of prenatal poly(I:C) exposure on spatial short-term
memory and social interaction (Bitanihirwe et al. 2010a, 2010b;
Richetto et al. 2013), suggesting that prenatal viral-like immune
activation leads to robust deﬁcits in these cognitive and behav-
ioral domains. Against the background of these impairments,
we further identiﬁed transcriptomic, epigenetic, and neuroana-
tomical abnormalities in offspring exposed to prenatal immune
activation. This approach thus allowed us to assess possible
molecular correlates of the behavioral and cognitive abnormal-
ities induced by prenatal immune challenge. For example, we
identiﬁed a positive correlation between accumbal (and, to a
lesser extent, prefrontal) expression levels of myelination-
related genes such as MAG, MOG, MOBP and MAL and the ani-
mals’ behavioral performance, especially when considering the
domains of social interaction. These correlations, however,
should be interpreted with caution in view of the relatively
modest group sizes.
Our genome-wide gene expression analyses revealed tran-
scriptomic alterations in a number of genes, many of which
have been associated with schizophrenia. In particular, when
comparing our results with the currently recognized risk genes
for schizophrenia, 5 of the affected genes in the mPFC
(ADORA2A, CNP, DRD2, MAG, PPP1RB1), and 21 of the affected
genes in the NAc (APOD, CACNA 1B, DRD3, FOXP2, GLS,
GRIN2A, HIST1H2BC, HRT1A, HRT2A, HRT4, MAG, MGST1,
MYO16, OXT, PBRM1, PDYN, ST3GAL1, SULT4A1, TSNAX,
VAMP4) fall into this list (Butler et al. 2016). In agreement with
previous reports by Connor et al. (2012) and Smith et al. (2007),
prenatal immune activation leads to less extensive gene
expression changes in the mPFC (n = 116 genes) as compared to
the NAc (n = 251 genes) (Smith et al. 2007; Connor et al. 2012).
Moreover, consistent with these earlier reports (Connor et al.
2012), most transcripts in prenatally infected offspring show
less than 2-fold changes from the control group. Such effect
sizes are not unprecedented given the early prenatal timing of
the environmental insult, which typically leads to pathological
changes in brain and behavior that are widespread but often
relatively mild in terms of effect size (Meyer et al. 2007).
Despite the magnitude and number of changes, these effects
may still be pathophysiologically relevant and may prime the
organism to altered neuronal functions when challenged with
other environmental stressors or behavioral and cognitive
demands.
Notably, some of our data are consistent with previous ﬁnd-
ings in the prenatal inﬂuenza infection model developed by
Fatemi and colleagues, suggesting that at least parts of the
transcriptomic changes induced by prenatal inﬂuenza exposure
may be mediated indirectly via activation of the maternal
immune system (Fatemi et al. 2012). As in the prenatal inﬂu-
enza model, we observed changes in the expression of FOXP2,
PPP1R1B, DEAD box polypeptide, ATP13, CRYGE, and various
other genes implicated in the pathophysiology of schizophrenia
and autism (Fatemi et al. 2005, 2008, 2009a, 2009b). The similar-
ities between the 2 models are even more evident when consid-
ering the region-overlapping transcriptomic effects identiﬁed
here. Indeed, among the 14 genes commonly affected in the
mPFC and NAc, 6 of these (MAG, MOG, MOBP, MAL, CLDN11
and MYRF) are similarly affected by prenatal exposure to inﬂu-
enza (Fatemi et al. 2005, 2009a) and are involved in myelin
functionality and stability. The consistency between our ﬁnd-
ings and those reported by Fatemi and colleagues thus suggests
that reduced expression of markers of myelin stability and
functionality could be a long-lasting molecular signature of
various prenatal immune challenges. Additional support for
this hypothesis also stems from recent proteomic analyses
demonstrating similar effects of prenatal viral-like immune
activation on myelination-related proteins (Farrelly et al. 2015).
Indeed, Farrelly et al. (2015) also uncovered changes in myelin-
related proteins, such as MBP1 and rhombex 29, suggesting
that prenatal infection may contribute to neurodevelopmental
abnormalities through mechanisms involving myelin forma-
tion and functionality (Farrelly et al. 2015).
The effects of prenatal immune activation on myelin-
related dysfunctions are particularly interesting in light of the
potential role of myelination and white matter abnormalities
present in schizophrenia and other neurodevelopmental disor-
ders (Haroutunian et al. 2014; Mighdoll et al. 2015; Chavarria-
Siles et al. 2016). Indeed, myelin provides the basis for rapid
impulse conduction in the central nervous system and acts as
electrical insulation for the unsheathed axon, which both helps
to preserve the amplitude and increase the conduction velocity
of the propagating axonal potential (Nave and Werner 2014;
Normand and Rasband 2015). Given these essential functions,
it is not surprising that damage to the myelin structure has
been implicated in a variety of neurodevelopmental disorders.
The expression of MAG, MOG, MOBP, MAL and CLDN11 is
physiologically enriched in myelin-forming oligodendrocytes
and is downregulated in schizophrenic subjects (Hakak et al.
2001; Aston et al. 2004; Katsel et al. 2005; Le-Niculescu et al.
2009). Moreover, alterations in white matter, such as volume
reductions in prefrontal areas and increased density in subcor-
tical areas, morphologic abnormalities in oligodendroglia and
myelin-related gene abnormalities have all been related to
schizophrenia (Sanﬁlipo 2000a, 2000b; Davis and Haroutunian
2003; Davis et al. 2003; Connor et al. 2011). Our ﬁndings here,
together with those reported by Fatemi et al. and Farrelly et al.
(Fatemi et al. 2005, 2009a, 2009b; Farrelly et al. 2015), highlight
that the pathological relationship between prenatal infection
and neurodevelopmental psychiatric disorders involves the dis-
ruption of myelination-related processes.
We performed additional MRI and immunohistochemical
investigations to examine whether abnormal expression of
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myelination-related genes may have an impact on gray and
white matter structure. In general, our brain-wide voxel-wise
analysis revealed sparse differences in volume and T1, but
widespread decreases in T2 and increases in the MWF between
CON and POL offspring. In the NAc, we observed focal increases
in T1, decreases in T2, but no change in the MWF, whereas the
mPFC of POL offspring showed signiﬁcant decreases in T2 and
an apparent increase in the MWF. Our data represent the ﬁrst
application of mcDEPOST to a rodent model of an epidemiologi-
cally informed risk factor for neurodevelopmental disorders. A
single prior clinical study has utilized mcDESPOT in a small
number of adult individuals with ASD (N = 14) (Deoni et al.
2015). This revealed increases in T1 bilaterally within the cere-
bellum, thalamus, and internal capsule; and in right temporal
and occipital WM, accompanied by decreases in the MWF, but
no change in T2. Our T1 data, especially in the cerebellum, thus
partially overlap with these data, but the majority of our ﬁnd-
ings go in the opposite direction. This may not be surprising
since we only model a single disease factor, whereas most neu-
rodevelopmental disorders such as ASD are clearly multifactor-
ial in origin.
A previous longitudinal in vivo MRI study in rats has demon-
strated that exposure to poly(I:C)-induced immune activation
on GD 15 leads to an abnormal developmental trajectory of
brain maturation (Piontkewitz et al. 2011). This raises the ques-
tion of whether our cross-sectional MRI data are representative
of a similar phenomenon in the mouse brain following immune
activation on GD 17. Longitudinal in vivo MRI studies of typically
maturing C57/Bl6 mice suggest 2 important ﬁndings in this con-
text. First, most gray matter regions reach their ﬁnal volume
within the ﬁrst 8 postnatal weeks (Hammelrath et al. 2015).
Second, there is an initial decrease in T2 from 3 to 8 weeks post-
natal, after which T2 steadily increases up to 24 weeks of age
(Hammelrath et al. 2015). Taken together, our ﬁndings of wide-
spread decreases in T2 in POL offspring at 12 weeks postnatal
suggest a delay in the normal process of mouse brain matur-
ation following maternal immune activation. Although longitu-
dinal in vivo MRI studies will be helpful to clarify this, we have
recently shown that prenatal immune activation on GD 17 in
mice leads to an “immature” cortical GABAergic network in
early adulthood, supporting a “delayed maturation” hypothesis
(Richetto et al., 2014). Importantly, rats and mice show differen-
tial timescales of brain maturation, thus these ﬁndings may
not translate precisely across species (Mengler et al. 2014;
Hammelrath et al. 2015)
How do these macroscale ﬁndings relate to those at the
transcriptional level, particularly with respect to myelination?
Our postmortem immunohistochemistry analysis of the mPFC
is in line with the gene expression data, with no change in
MBP, but a decrease in MOBP. What then, underlines the
changes in T1 and T2, and in particular the seemingly paradox-
ical increase in the MWF in the PFC of POL offspring? Prior stud-
ies have shown that the MWF derived from a conventional
multiple spin-echo MCR approach are strongly correlated with
histological estimates of myelin content (Webb et al. 2003;
Stanisz et al. 2004; Laule et al. 2008, 2006), but to the best of our
knowledge this has not been done for the mcDESPOT MCR
technique. We have recently shown that the mcDESPOT-
derived MWF is sensitive to demyelination of white matter
tracts in the mouse brain induced by chronic cuprizone expos-
ure (Wood et al. 2016a, 2016b). Speciﬁcally, demyelinated
regions showed higher values of T1 and T2, with a correspond-
ing decrease in the MWF (Wood et al. 2016a, 2016b). In the cur-
rent study, we observed increases in T1 and decreases in T2 in
the NAc and mPFC, respectively (as well as in other brain
regions). Although preliminary, due to low statistical power,
our correlation analysis suggests that the increase in prefrontal
MWF signals is not related to the area fraction of MBP, but is
negatively correlated to T2 in both CON and POL offspring.
Furthermore, there is a negative correlation between MOBP
area fraction and T2 in the PFC in POL offspring only. These
data are in good agreement with observations that T1 and T2
are inﬂuenced by the entry of precursory macromolecules for
myelin and myelin-associated proteins during human brain
maturation (Paus et al. 2001). Furthermore, this is consistent
with the robust topographical overlap between decreases in T2
and apparent increases in the MWF in our MRI dataset.
Taken together, this suggests that the increase in MWF is
not caused by an increase in the quantity of myelin itself, but
changes to its ‘quality’. Speculatively, decreased levels of mye-
lin stability proteins would be predicted to affect the micro-
structure of the myelin sheath, altering the g-ratio. For
example, if the myelin sheath is less compact, the fraction of
water trapped between lipid bilayers could potentially increase,
thereby driving an apparent MWF increase. Importantly, The
function of MOBP has been associated with the compaction
and stabilization of myelin membranes (Gould et al. 2000;
Montague et al. 2006). This hypothesis could be tested by
exploiting recent advances in the combination of myelin con-
tent information (obtained with mcDESPOT MCR) with informa-
tion about axonal microstructure obtained through multi-shell
DTI (Melbourne et al. 2014; Dean et al. 2016). Changes in the
relaxation properties of brain tissues may however also reﬂect
other biological processes, including iron accumulation and
changes in tissue water compartmentalization through chan-
ges in axon ﬁber size, density or coherence (Paus et al. 2001;
MacKay et al. 2006). Whilst further investigations are therefore
warranted, our current data provide initial evidence suggesting
that abnormal expression of myelination-related genes can be
plausibly linked to changes in tissue relaxation time.
Nevertheless, they also show that further validation of the
mcDESPOT model at the postmortem level in rodent models
would be helpful to the ﬁeld.
Lastly, our study provides the ﬁrst report concerning hyper-
methylation of the MOBP promoter following prenatal immune
activation. Hence, we identify an epigenetic mechanism that
could possibly underlie the effects of prenatal infection on
long-lasting transcriptomic changes in myelination-related
genes. The identiﬁed correlations between MOBP DNA methyla-
tion and mRNA levels readily support this notion. It should be
pointed out, however, that the correlative analyses between
DNA methylation and gene expression levels were based on
small sample sizes (N = 5–6 animals per group), and therefore,
they might have been underpowered. Nevertheless, our ﬁnd-
ings are in agreement with previous studies showing prenatal
immune activation in rats or mice can induce that various epi-
genetic changes such as DNA hyper- or hypomethylation, his-
tone modiﬁcations, and altered micro-RNA expression, some of
which likely affect the expression of corresponding genes
(Connor et al. 2012; Tang et al. 2013; Basil et al. 2014; Labouesse
et al. 2015; Richetto et al., 2016).
In conclusion, our study further characterizes the molecular
signature of prenatal viral-like immune activation in the off-
spring’s corticostriatal regions. In particular, prenatal infection-
induced transcriptomic changes in myelination-related gen-
es seems to be a common pathological feature in multiple brain
areas. The current study also provides the ﬁrst voxel-wise assess-
ment of brain volume and application of MCR methodology,
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which together suggest a putative delay in brain maturation
following prenatal viral-like infection. Furthermore, the study
provides preliminary evidence that these macrostructural
abnormalities may be plausibly linked to abnormal expression
of myelination-related genes in the absence of demyelination
per se. Future investigations are therefore needed to conﬁrm
the mechanistic links between these molecular modiﬁcations
and MR-detectable brain alterations occurring in prenatally
infected offspring. Nevertheless, our data highlight the power
of combining system level assessments (MRI) with invasive
cellular and molecular phenotyping of the same animal post-
mortem in the elucidation of disease-relevant mechanisms.
Supplementary Material
Supplementary material can be found at: http://www.cercor.
oxfordjournals.org/.
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